HIV kinase variants
US10407669B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 27, 2016 |
| Grant date | Sep 10, 2019 |
| Priority date | — |
| Expiry date | Jul 27, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y401/01033
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Described are HIV kinase variants showing an improved activity in converting 3-hydroxyisovalerate (HIV) into 3-phosphonoxyisovalerate (PIV), methods for the production of PIV using such enzyme variants as well as methods for the production isobutene in a subsequent reaction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.